Immunovant, Inc. presented company data at the American Thyroid Association meeting and simultaneously sought approval from the FDA.
1 report, 1 independent
Updated Sep 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Immunovant, Inc. presented company data at the American Thyroid Association meeting and simultaneously sought approval from the FDA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
American Thyroid Association
organization
Nothing else this week.
- FDA
Coverage
Newest first; wire copies grouped- GlobeNewswireImmunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients First-ever potentially disease-modifyin